RCM
TDACU

Radcliffe Capital Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Radcliffe Capital Management’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119,539
Closed -$1.2M – 44
2024
Q4 		$1.2M Buy
+119,539
New +$1.2M 0.14% 38

Other funds holding TDACU

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Radcliffe Capital Management's TDACU Position: Q1 2025 in Review

Radcliffe Capital Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 119,539 shares — an estimated $1.2M sold.

Radcliffe Capital Management first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $1.2M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • Radcliffe Capital Management reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • Radcliffe Capital Management sold 119,539 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $1.2M.
  • Radcliffe Capital Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • Radcliffe Capital Management's Translational Development Acquisition Corp Units position peaked at $1.2M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on Radcliffe Capital Management's 13F filing for Q1 2025, filed 15 May 2025.